Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-003734
Filing Date
2025-02-13
Accepted
2025-02-13 14:35:28
Documents
73
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q veru20241231_10q.htm   iXBRL 10-Q 1367572
2 EXHIBIT 10.1 ex_775143.htm EX-10.1 17698
3 EXHIBIT 31.1 ex_758046.htm EX-31.1 9091
4 EXHIBIT 31.2 ex_758047.htm EX-31.2 9094
5 EXHIBIT 32.1 ex_758048.htm EX-32.1 6229
  Complete submission text file 0001437749-25-003734.txt   6957718

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA veru-20241231.xsd EX-101.SCH 62060
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE veru-20241231_cal.xml EX-101.CAL 59045
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE veru-20241231_def.xml EX-101.DEF 501236
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE veru-20241231_lab.xml EX-101.LAB 414141
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE veru-20241231_pre.xml EX-101.PRE 521659
76 EXTRACTED XBRL INSTANCE DOCUMENT veru20241231_10q_htm.xml XML 920109
Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

EIN.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-13602 | Film No.: 25619464
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)